David Martin is the Associate Director for Real World Evidence Analytics in the Office of Medical Policy at the FDA Center for Drug Evaluation and Research. He oversees demonstration projects intended to support the agency’s evaluation of real world evidence, evaluates real world evidence use cases, and contributes to medical policy development mandated by the 21st Century Cures Act. Key focus areas include FDA-Catalyst and PCORI pragmatic trials as well as replication of clinical trial results with non-interventional study designs. He is also the principal investigator for the first study to capture patient-provided primary data through a mobile device application, store it in a secure cloud based repository, and link it to secondary electronic data in Sentinel and PCORnet. As a former Branch Chief, Division Director, and Acting Deputy Office Director in the Center for Biologics Evaluation and Research, Dr. Martin led analyses of spontaneous reports, formalized risk management planning, and helped develop the Sentinel system. He also served on detail as the FDA Liaison to the European Medicines Agency. Before joining the FDA, Dr. Martin practiced flight and occupational medicine in the U.S. Air Force. He earned his undergraduate degree at the Citadel and his M.D. and M.P.H. at the Johns Hopkins University.